Ramkhamhaeng Hospital Public Company (RAM) Fair Value & Analysis
Healthcare · TH · Market cap 21.5B THB
Fair value as of: Jul 16, 2026
From 26 valuation models · updated 25 days ago
Share price −0.6% over the past month.
A solid business, screening 87% undervalued on our models.
What matters now
- The price is below even our cautious bear case (18.29 THB). The market is more pessimistic than our downside scenario.
- The model range is unusually wide (18.29 THB to 55.89 THB). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- Solid quality (51/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.
How to read this chart
60‑month range 16.61 THB – 63.14 THB · fair‑value band 18.29 THB – 55.89 THB · the 17.90 THB price screens below the 33.50 THB fair value. Dashed = 300-day average. As of Jul 16, 2026.
Analysis
Ramkhamhaeng Hospital Public Company (RAM) currently trades at 17.90 THB, while our model-based Fair Value estimate is 33.50 THB, implying the stock looks roughly 87.2% undervalued today. The Quality Score stands at 51/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, Ramkhamhaeng Hospital Public Company generated revenue of 17.5B THB at a net margin of 15.5%. Revenue grew 100.9% year over year. It earns a return on equity of 8.9%. Net debt stands at 15.6B THB. Fundamentals as of Jul 16, 2026
Our scenario range runs from 18.29 THB (bear case) to 55.89 THB (bull case); at 17.90 THB, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 21% below its 52-week high and 8% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at 87%, RAM screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 26 models by family
Widest divergence: Growth Earnings (45.61 THB) versus Dividend Discount (2.28 THB). Highest evidence: Growth DCF (80).
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 16, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 49 · Market factors (momentum, volatility) 52
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Ramkhamhaeng Hospital Public Company Limited, together with its subsidiaries, engages in the hospital business in Thailand. It operates in two segments, Hospital and Other.
Full company description
Ramkhamhaeng Hospital Public Company Limited, together with its subsidiaries, engages in the hospital business in Thailand. It operates in two segments, Hospital and Other. The company is involved in the operation of hospitals and hospitals in social security; provisions of medical care and treatment for various diseases; and sale of medical equipment, instruments, and pharmaceutical products. It also engages in property development; IT consulting and software development; and training activities. The company was founded in 1976 and is based in Bangkok, Thailand.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Ramkhamhaeng Hospital Public Company reported revenue of 14.8B THB in FY2025 versus 12.7B THB in FY2021, a compound +3.9%/yr. Reported net income was 2.8B THB in FY2025, compounding −9.5%/yr from FY2021.
Watch RAM: get an alert when its fair value changes →
Peer Group
Medical Care Facilities · 262 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $378.85 | $554.93 | +46% |
| Fresenius SE FRE | €41.73 | €32.15 | -23% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.58 SGD | 1.44 SGD | -44% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| Rede D'Or São Luiz S.A RDOR3 | R$36.01 | R$47.31 | +31% |
| DaVita Inc DVA | $231.61 | $255.97 | +11% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,955 | ₹2,955 | -67% |
| Fresenius Medical Care AG FMS | $24.68 | $45.60 | +85% |
| Aier Eye Hospital Group 300015 | ¥8.68 | ¥7.67 | -12% |
Compare Ramkhamhaeng Hospital Public Company with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Ramkhamhaeng Hospital Public Company (RAM) overvalued or undervalued?
What is the fair value of RAM?
What is the quality score of RAM?
What is the revenue of Ramkhamhaeng Hospital Public Company (RAM)?
What is the net profit margin of RAM?
Does Ramkhamhaeng Hospital Public Company pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Ramkhamhaeng Hospital Public Company and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.